The cumulative risk of developing gastric cancer for CDH1 pathogenic variant carriers in their lifetime is estimated to be 70%, and there is also a 42% risk of lobular breast cancer (LBC) for women [5, 6]. This evidence concerns the gene CDH1 and CDH1-related diffuse gastric and lobular breast cancer syndrome.